title: Comparison of Clinical Manifestations and Survival Outcomes between Neuroendocrine Tumor and Squamous Cell Carcinoma of the Uterine Cervix: Results from a Tertiary Center in Southern Thailand.
abstract: OBJECTIVE
  To study the clinical manifestations and survival outcomes of neuroendocrine tumor of the uterine cervix (NTUC) and compare them with those of squamous cell carcinoma (SCCA) MATERIAL AND METHOD: A case-control study was conducted. In the study group, we included patients whose tumors were described in the original pathology reports as NTUC. For the control group, we calculated the sample size based on a formula according to survival rate. The ratio of cases to controls was 1:4. Patients with a diagnosis of SCCA of the uterine cervix and treated between January 2003 and December 2011 in Son gklanagarind Hospital were included in the control group according to stage and year of NT UC diagnos is. The patients 'characteristics, method of treatment, treatment outcomes, and survival of the two groups were compared. The prognostic factors among patients with NTUC were analyzed using the Cox regression.
  
  
  RESULTS
  Of the 2,835 cervical carcinoma cases studied, 44 (1.6%) were NTUC. NTUC patients had a lower mean age at diagnosis, received more multimodality treatments, had a lower complete response rate, a higher recurrence rate, and more distant metastasis than their SCCA counterparts. A significantly lower 2-year and 5-year survival was detected in NTUC compared with SCCA (62% and 52% vs. 97% and 85%, respectively, p < 0.01). In the univariate analysis, the number of sexual partners, stage of disease, surgery treatment, status of response, and site of recurrence predicted a poorer overall survival in NTUC. However, these factors were not found to be statistically significant prognostic factors on multivariate analysis.
  
  
  CONCLUSIONS
  A poorer treatment outcome and prognosis were found in NTUC compared with SCCA. Moreover a poorer prognosis was observed in NTUC patients with an advanced-stage disease, non-surgery treatment, progressive disease, and distant metastasis recurrence than in those with SCCA patients. Multimodality treatments should be considered in NTUC to improve survival. Additionally close monitoring may be necessary in this group of patients.
authors.forename: Kanchid
authors.initials: K
authors.lastname: Sodsanrat
authors.forename: Nungrutai
authors.initials: N
authors.lastname: Saeaib
authors.forename: Tippawan
authors.initials: T
authors.lastname: Liabsuetrakul
mesh_terms: D000328:Adult; D000367:Age Factors; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000401:mortality* / Q000473:pathology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000473:pathology; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000401:mortality* / Q000473:pathology*; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D013785:Thailand; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000401:mortality* / Q000473:pathology*